A completed pharmaceutical manufacturing project developed for the formulation, filling and packaging of human insulin products.
The construction project covered approximately 2,250 m² within Lilly Egypt’s larger manufacturing site in 6th of October City.
The facility produced Humulin insulin formulations in R, NPH and 70/30 vial formats for both the Egyptian market and export destinations.
The manufacturing site was designed to operate according to international Good Manufacturing Practice standards.